Death and digoxin: Stop me if you've heard this one before

Canadian Journal of Cardiology

Volumn 30, Issue 10, 2014, Pages 1145-1147

  Wyse, D George ^a  

^a LIBIN CARDIOVASCULAR INSTITUTE OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DIGOXIN; PLACEBO; ANTIARRHYTHMIC AGENT;

CARDIOVASCULAR MORTALITY; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; DIASTOLIC HEART FAILURE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG SAFETY; EDITORIAL; HEALTH CARE DELIVERY; HEALTH CARE SYSTEM; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART INFARCTION; HOSPITALIZATION; HUMAN; INFORMATION PROCESSING; LOW DRUG DOSE; PATIENT PREFERENCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SINUS RHYTHM; BRAIN ISCHEMIA; COMPLICATION; MORTALITY; STROKE;

ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; BRAIN ISCHEMIA; DIGOXIN; HUMANS; STROKE;

EID: 84908051544     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2014.05.003     Document Type: Editorial

References (11)

1. Chao T.F., Liu C.J., Chen S.J., et al. Does digoxin increase the risk of ischemic stroke and mortality in atrial fibrillation? A nationwide population-based cohort study. Can J Cardiol 2014, 30:1190-1195.
2. The effect of digoxin on mortality and morbidity in patients with heart failure. NEngl J Med 1997, 336:525-533. Digitalis Investigation Group.
3. Whitbeck M.G., Charnigo R.J., Khairy P., et al. Increased mortality among patients taking digoxin-analysis from the AFFIRM study. Eur Heart J 2013, 34:1481-1488.
4. Gheorghiade M., Fonarow G.C., van Velduisen D.J., et al. Lack of evidence of increased mortality among patients with atrial fibrillation taking digoxin: findings from post hoc propensity-matched analysis of the AFFIRM trial. Eur Heart J 2013, 34:1489-1497.
5. Kober L., Torp-Pedersen C., Gadsboll N., Hildebrandt P., Hoilund-Carlsen P.F. Is digoxin and independent risk factor for long-term mortality after acute myocardial infarction?. Eur Heart J 1994, 15:382-388.
6. Corely S.D., Epstein A.E., DiMarco J.P., et al. Relationships between sinus, rhythm, treatment and survival in Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Study. Circulation 2004, 109:1509-1513.
7. Ahmed A., Rich M.W., Fleg J.L., et al. Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary Digitalis Investigation Group trial. Circulation 2006, 114:397-403.
8. Ahmed A., Rich M.W., Love T.E., et al. Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial. Eur Heart J 2006, 27:178-186.
9. Ahmed A., Pitt B., Rahimtoola S.H., et al. Effects of digoxin at low serum concentrations on mortality and hospitalization in heart failure: a propensity matched study of the DIG trial. Int J Cardiol 2008, 23:138-146.
10. AMA Manual of Style. SI Conversion Calculator. Available at: . Accessed February 2,2014. http://www.amamanualofstyle.com/page/si-conversion-calculator.
11. Freeman J.V., Jang J., Sung S.H., Hlatky M.A., Go A.S. Effectiveness and safety of digoxin among contemporary adults with incident systolic heart failure. Circ Cardiovasc Qual Outcomes 2013, 6:525-533.